Sponsored by:

Molecular Imaging: Page 417

IBA gets FDA nod for pencil-beam scanning
By AuntMinnie.com staff writers
Radiopharmaceutical firm Ion Beam Applications (IBA) has received clearance from the U.S. Food and Drug Administration for its pencil-beam scanning treatment option for proton therapy.
December 18, 2008
FDG-PET/CT recommended for staging Hodgkin's disease
By Wayne Forrest
A British study confirms the high sensitivity and specificity of PET/CT in identifying focal bony disease in patients with Hodgkin's disease, according to research presented at the recent 2008 RSNA meeting. The results further suggest that the imaging modality can play an important role in initial staging of the disease.
December 18, 2008
Alliance Imaging buys Shared PET
By AuntMinnie.com staff writers
Imaging services firm Alliance Imaging has acquired mobile and fixed-site PET/CT provider Shared PET Imaging.
December 17, 2008
Positron hires medical director
By AuntMinnie.com staff writers
PET developer Positron of Houston has hired Dr. Michael Merhige as its medical director.
December 16, 2008
IBA opens Dallas PET facility
By AuntMinnie.com staff writers
Radiopharmaceutical firm Ion Beam Applications (IBA) has opened a new PET radiopharmaceutical production facility in Dallas.
December 16, 2008
AECL's NRU reactor back online
By AuntMinnie.com staff writers
Atomic Energy of Canada's (AECL) National Research Universal (NRU) nuclear reactor is up and running again after several days offline for maintenance.
December 16, 2008
AuntMinnie.com Molecular Imaging Insider
By Wayne Forrest
December 14, 2008
Aposense begins trial
By AuntMinnie.com staff writers
Molecular imaging and therapy developer Aposense has begun a phase II trial of its apoptosis molecular imaging agent.
December 14, 2008
Siemens gets FDA OK for IQ-SPECT
By AuntMinnie.com staff writers
Siemens Healthcare has received clearance from the U.S. Food and Drug Administration for IQ-SPECT.
December 14, 2008
Nuclear myocardial perfusion imaging: Vulnerable to self-referral?
By Kate Madden Yee
Nuclear myocardial perfusion imaging (MPI) can be a powerful tool against heart disease, but the procedure is costly. Researchers are investigating how MPI is used -- and by whom -- to evaluate whether overuse of the technology contributes to inflated healthcare costs.
December 14, 2008
2008 12 10 15 41 48 11 Slide8 Ic Insider
IBA responds to FDA warning letter
By AuntMinnie.com staff writers
Radiopharmaceutical firm Ion Beam Applications (IBA) has responded to a warning letter from the U.S. Food and Drug Administration related to manufacturing practices for PET radiotracers at a facility in Virginia.
December 10, 2008
PET SUV measurements vary between facilities
By Eric Barnes
For lung cancer patients undergoing chemotherapy and radiation, PET can be a good way to monitor and even predict treatment response. But the response measured in standardized uptake values (SUVs) can vary significantly depending on the facility in which SUV is measured.
December 9, 2008
Previous Page
Page 417 of 612
Next Page